144 related articles for article (PubMed ID: 10218722)
1. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Fogari R; Zoppi A; Corradi L; Preti P; Mugellini A; Lusardi P
J Cardiovasc Pharmacol; 1999 Apr; 33(4):534-9. PubMed ID: 10218722
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
[TBL] [Abstract][Full Text] [Related]
3. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
Fogari R; Zoppi A; Tettamanti F; Malamani G; Pasotti C
Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1287-90. PubMed ID: 1826213
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker effects on plasma lipids in antihypertensive therapy: importance of the duration of treatment and the lipid status before treatment.
Fogari R; Zoppi A; Tettamanti F; Poletti L; Lazzari P; Pasotti C; Corradi L
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S76-80. PubMed ID: 11527140
[TBL] [Abstract][Full Text] [Related]
5. Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension.
Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Maiwald C
Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):597-604. PubMed ID: 2905341
[TBL] [Abstract][Full Text] [Related]
6. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
[TBL] [Abstract][Full Text] [Related]
8. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
Silke B; Guy S; Riddell JG
J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
[TBL] [Abstract][Full Text] [Related]
9. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
[TBL] [Abstract][Full Text] [Related]
10. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles.
Vyssoulis GP; Karpanou EA; Pitsavos CE; Skoumas JN; Paleologos AA; Toutouzas PK
Eur Heart J; 1992 Nov; 13(11):1506-13. PubMed ID: 1361175
[TBL] [Abstract][Full Text] [Related]
12. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.
Milne RJ; Vander Hoorn S; Jackson RT
Pharmacoeconomics; 1997 Sep; 12(3):384-408. PubMed ID: 10170463
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension.
Vyssoulis GP; Karpanou EA; Pitsavos CE; Toutouza MA; Paleologos AA; Toutouzas PK
Am J Cardiol; 1991 May; 67(11):987-92. PubMed ID: 1673284
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
[TBL] [Abstract][Full Text] [Related]
15. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
Dimmitt SB; Williams PD; Croft KD; Beilin LJ
Clin Sci (Lond); 1998 Jun; 94(6):573-8. PubMed ID: 9854453
[TBL] [Abstract][Full Text] [Related]
16. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
Balasubramaniam S; Simons LA; Hickie JB; Chang S
Artery; 1990; 17(2):60-70. PubMed ID: 1968740
[TBL] [Abstract][Full Text] [Related]
17. Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective beta-blockers on arterial pulse wave velocity in normotensive subjects.
Kahonen M; Ylitalo R; Koobi T; Turjanmaa V; Ylitalo P
Gen Pharmacol; 2000 Oct; 35(4):219-24. PubMed ID: 11827729
[TBL] [Abstract][Full Text] [Related]
18. Alterations in plasma lipids consequent to endurance training and beta-blockade.
Morton AR; Stanforth PR; Freund BJ; Joyner MJ; Jilka SM; Hartzell AA; Ewy GA; Wilmore JH
Med Sci Sports Exerc; 1989 Jun; 21(3):288-92. PubMed ID: 2567483
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids.
van Hoof R; Desager JP; Harvengt C; Fagard R; Lijnen P; Peerenboom P; Staessen J; Thijs L; Van Mieghem W; Amery A
J Cardiovasc Pharmacol; 1992 Aug; 20(2):268-73. PubMed ID: 1381018
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.
D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
Am J Cardiol; 1993 Jan; 71(1):82-7. PubMed ID: 8093585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
